Correction to: Drugs (2023) 83:1635–1643 https://doi.org/10.1007/s40265-023-01962-w


In the published PDF version, Section 2.1 Pharmacodynamics, second paragraph, sixth sentence, which currently reads:


In this study, a single subcutaneous injection of motixafortide (part 1: 1 mg/kg; part 2: 1.25 mg/kg) resulted in the collection of ≥ 2 × 106 CD34+ cells/kg within two leukapheresis procedures (primary endpoint) in 11 (85%) of 13 adult allogenic donors in part 1 and 11 (100%) of 11 of 13 adult allogenic donors in part 2. The collection of ≥ 2 × 106 CD34+ cells/kg in one leukapheresis procedure occurred in 11 (85%) of 13 allogenic donors and 8 (73%) of 11 allogeneic donors, respectively.


Should read:


In this study, a single subcutaneous injection of motixafortide (part 1: 1 mg/kg; part 2: 1.25 mg/kg) resulted in the collection of ≥ 2 × 106 CD34+ cells/kg within two leukapheresis procedures (primary endpoint) in 11 (85%) of 13 adult allogenic donors in part 1 and 11 (100%) of 11 adult allogenic donors in part 2. The collection of ≥ 2 × 106 CD34+ cells/kg in one leukapheresis procedure occurred in 11 (85%) of 13 allogenic donors and 8 (73%) of 11 allogeneic donors, respectively.


The original PDF version of the article has been corrected.